Dr. Nipun Verma @drnipunverma.bsky.social · 07/03/2025🚨 New Insights in Cirrhosis! 🚨 www.journal-of-hepatology.eu/article/S016... Our study reveals Non-Acute Decompensation (NAD) is a distinct clinical state, different from compensated cirrhosis & acute decompensation (AD) @rajivjalan.bsky.social @jhepatology.bsky.social @akashroyy.bsky.social 183
Reposted by Dr. Nipun Vermamattiasmandorfer.bsky.social @mattiasmandorfer.bsky.social · 05/03/2025@bavenocoop.bsky.social Research Committee Baveno VIII Pre-Symposium, here we go! 👍 103 members watching online 👉 High interest in designing clinical studies on PH. #liversky 072
Reposted by Dr. Nipun VermaThomas Reiberger @reibergerthomas.bsky.social · 06/03/2025Systemic inflammation🔥(SI) is a major driver of #liver disease progression in patients with decompensated #cirrhosis. Dr. Lukas Hartl now demonstrated in #JHEPReports that #TIPS not only controls #PH-related decompensation but also effectively and sustainedly decrease #SI (#IL6 levels. 🔗 t.ly/A39-U 053
Reposted by Dr. Nipun VermaHanna Blaney, MD, MPH @blaneymd.medsky.social · 05/03/2025Please delve deeper into “social” drinking with your patients, especially in those with evidence of liver disease. More often than not, drinking that is considered socially acceptable is harmful to the liver. Sometimes a brief intervention/educational moment is enough to save a liver! #liversky 041
Reposted by Dr. Nipun VermaJournal of Hepatology @jhepatology.bsky.social · 06/03/2025🆕Article in press❕ A phase IIb randomised-controlled trial of the FFAR1/FFAR4 agonist icosabutate in MASH Full text here👉https://bit.ly/4iucrzV More information here👉https://bwnews.pr/4hadNie #OpenAccess #LiverSky 022
Reposted by Dr. Nipun VermaElliot Tapper @ebtapper.bsky.social · 04/03/2025Spicy! Adding lasix to the management of hepatorenal syndrome might be ok if you bump the MAP with pressors @juancarlosqvelez.bsky.social doi.org/10.1016/j.ek... #nephsky #liversky 2258
Reposted by Dr. Nipun VermaAtoosa Rabiee @atoosarabiee.bsky.social · 03/03/2025Highlighting role of hepatology in the spectrum of HCC care In this study Impact of liver decom on clinical outcomes on atezobeva 📌OS better in CP A vs CP B 📌No differences in TTP/safety 📌Liver decomp: 28% CP A vs 51% CP B 📌41% resume after decomp #Liversky www.cghjournal.org/article/S154... 073
Reposted by Dr. Nipun VermaAtoosa Rabiee @atoosarabiee.bsky.social · 28/02/2025What an honor to be speaking at Hot Topics at AASLD 2024 hosted by ILBS invited by one and only Dr. Shiv Sarin :) #liversky 161
Dr. Nipun Verma @drnipunverma.bsky.social · 25/02/2025🚀 AI & ML are transforming liver disease care! 🔬our @akashroyy.bsky.social review explores how machine learning enhances diagnosis & outcome prediction in alcohol-related & metabolic dysfunction-associated steatotic liver diseases (MASLD). 🔍 🔗 oaepublish.com/articles/mtod.… #AI #Liver 010
Reposted by Dr. Nipun VermaDECISION Horizon2020 @decision4liver.bsky.social · 19/12/2024🔵 ClustALL paper: This innovative clustering method addresses patient heterogeneity in acutely decompensated #cirrhosis, identifying subgroups with prognostic value to improve trials and personalized care. Read more: translational-medicine.biomedcentral.com/articles/10.... #LiverSkytranslational-medicine.biomedcentral.comA robust clustering strategy for stratification unveils unique patient subgroups in acutely decompensated cirrhosis - Journal of Translational MedicineBackground Patient heterogeneity poses significant challenges for managing individuals and designing clinical trials, especially in complex diseases. Existing classifications rely on outcome-predictin... 061
Reposted by Dr. Nipun VermaArtificial Intelligence News @knowentry.com · 23/02/2025www.unite.ai/googles-ai-c... #AI #artificialintelligenceunite.aiGoogle’s AI Co-Scientist vs. OpenAI’s Deep Research vs. Perplexity’s Deep Research: A Comparison of AI Research AgentsRapid advancements in AI have brought about the emergence of AI research agents—tools designed to assist researchers by handling vast amounts of data, automating repetitive tasks, and even generating ... 032
Reposted by Dr. Nipun VermaRajiv Jalan @rajivjalan.bsky.social · 22/02/2025Fascinating discussion on PSVD, NCPF, Idiopathic portal hypertension ongoing in @jhepatology.bsky.social @valdig.bsky.social @ebtapper.bsky.social would be worth a skytutorial 052
